BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4935615)

  • 1. Responses of the ischemic myocardium to allopurinol.
    DeWall RA; Vasko KA; Stanley EL; Kezdi P
    Am Heart J; 1971 Sep; 82(3):362-70. PubMed ID: 4935615
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of allopurinol on the degree of early myocardial ischemia.
    Arnold WL; DeWall RA; Kezdi P; Zwart HH
    Am Heart J; 1980 May; 99(5):614-24. PubMed ID: 7369101
    [No Abstract]   [Full Text] [Related]  

  • 3. Some acute hemodynamic effects of large doses of sodium allopurinol in open-chested dogs.
    Ellis CH; Touw KB; Dickerson SW
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):355-67. PubMed ID: 4766552
    [No Abstract]   [Full Text] [Related]  

  • 4. Canine coronary vascular and cardiac responses to the prostaglandins.
    Nutter DO; Crumly HJ
    Cardiovasc Res; 1972 May; 6(3):217-25. PubMed ID: 5035593
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic evaluation of glucagon in symptomatic heart disease.
    Armstrong PW; Gold HK; Daggett WM; Austen WG; Sanders CA
    Circulation; 1971 Jul; 44(1):67-73. PubMed ID: 4934830
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulatory effects of oxprenolol, a new beta-adrenergic blocking agent.
    Reale A; Motolese M; Imhof P
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):288-93. PubMed ID: 4394124
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical aspects of early myocardial ischemia.
    Case RB; Nasser MG; Crampton RS
    Am J Cardiol; 1969 Dec; 24(6):766-75. PubMed ID: 5360230
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodynamic and biochemical results following administration of Allopurinol in healthy individuals].
    Sziegoleit W; Taube C; Terhaag B; Förster W
    Z Gesamte Inn Med; 1973 Aug; 28(15):465-6. PubMed ID: 4765560
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular function in potassium-depleted dogs.
    Bahler RC; Rakita L
    Am Heart J; 1971 May; 81(5):650-7. PubMed ID: 4928160
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics of aortic diastolic pressure decay with application to the continuous monitoring of changes in peripheral vascular resistance.
    Bourgeois MJ; Gilbert BK; Donald DE; Wood EH
    Circ Res; 1974 Jul; 35(1):56-66. PubMed ID: 4366522
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trial of the new coronary dilator hexobendine].
    Henke C; Dudik E; Steim H
    Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for a pathogenetic role of xanthine oxidase in the "stunned" myocardium.
    Charlat MI; O'Neill PG; Egan JM; Abernethy DR; Michael LH; Myers ML; Roberts R; Bolli R
    Am J Physiol; 1987 Mar; 252(3 Pt 2):H566-77. PubMed ID: 3826401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of cardiac function by allopurinol in patients undergoing cardiac surgery.
    Castelli P; Condemi AM; Brambillasca C; Fundarò P; Botta M; Lemma M; Vanelli P; Santoli C; Gatti S; Riva E
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):119-25. PubMed ID: 7723340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and coronary hemodynamic effects of glucagon.
    Rowe GG
    Am J Cardiol; 1970 Jun; 25(6):670-4. PubMed ID: 5420906
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic and metabolic effects of sodium nitroprusside on the performance and metabolism of regional ischemic myocardium;
    Luz PL; Forrester JS; Wyatt HL; Tyberg JV; Chagrasulis R; Parmley WW; Swan HJ
    Circulation; 1975 Sep; 52(3):400-7. PubMed ID: 1157236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.
    Stanton HC; Kirchgessner T; Parmenter K
    J Pharmacol Exp Ther; 1965 Aug; 149(2):174-82. PubMed ID: 4378559
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of isoproterenol on hemodynamic alterations, myocardial metabolism, and coronary flow in experimental acute myocardial infarction with shock.
    Kuhn LA; Kline HJ; Goodman P; Johnson CD; Marano AJ
    Am Heart J; 1969 Jun; 77(6):772-83. PubMed ID: 5770150
    [No Abstract]   [Full Text] [Related]  

  • 18. The systemic and coronary hemodynamic effects of lidoflazine.
    Thomsen JH; Stenlund RR; Corliss RJ; Sialer S; Rowe GG
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):15-23. PubMed ID: 5650324
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of nematocyst toxin of Physalia physalis (Portuguese Man-of-War) on the canine cardiovascular system.
    Hastings SG; Larsen JB; Lane CE
    Proc Soc Exp Biol Med; 1967 May; 125(1):41-5. PubMed ID: 4381803
    [No Abstract]   [Full Text] [Related]  

  • 20. Allopurinol reduces neointimal hyperplasia in the carotid artery ligation model in spontaneously hypertensive rats.
    Yamamoto Y; Ogino K; Igawa G; Matsuura T; Kaetsu Y; Sugihara S; Matsubara K; Miake J; Hamada T; Yoshida A; Igawa O; Yamamoto T; Shigemasa C; Hisatome I
    Hypertens Res; 2006 Nov; 29(11):915-21. PubMed ID: 17345792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.